<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對照品 > 標(biāo)準(zhǔn)品 > 分析標(biāo)準(zhǔn)品 >
    (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone-D7(Fenofibrate Impurity)
    產(chǎn)品基本信息
    產(chǎn)品編號:C375152
    產(chǎn)品名稱:(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone-D7 (Fenofibrate Impurity)
    產(chǎn)品CAS:
    規(guī)格含量:25mg
    產(chǎn)品價格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號: C375152
    名稱: (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone-D7 (Fenofibrate Impurity)
    別名: (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone-D7; 3-[4-(4-Chlorobenzoyl)phenoxy]-2-propane-D7; Fenofibrate Impurity F-D7
    參考CAS: 未標(biāo)記:154356-96-4
    分子式: C??H?D?ClO?
    外觀: Tan Solid
    熔點: 106-109°C
    分子量: 281.79
    儲存: 冰箱保存
    溶解度: Chloroform, Methanol
    類別: Building Blocks; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone-D7 is a labelled analogue of (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone (C375150), an impurity of Fenofibrate (F248640). Fenofibrate is a lipid regulating drug that is used to decrease the incidence of coronary disease. It is also used in patients who frequently experience dyslipidemia and hyperlipoproteinemia as a result of renal insufficiencies.
    參考文獻(xiàn)


    2011-2018 信陽萊耀生物科技有限公司 @ 信陽埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      精品蜜桃一区二区三区 | 出差的丰满新婚少妇 | 欧美高清操逼 | 青青青久草| 天美传奇传媒官网 |